Sunday, January 1, 2017

BRIEF-Natco Pharma launches Velpanat in Nepal

* Natco Pharma Ltd says Epclusa is used for the treatment of

patients with HCV Genotype 2 and 3

Source text - (http://bit.ly/2hIPKwp)

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)